Advertisement

Oral Medications

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lear W.
        • Kessler E.
        • Solish N.
        • et al.
        An epidemiological study of hyperhidrosis.
        Dermatol Surg. 2007; 33: S69-S75
        • Cerfolio R.J.
        • De Campos J.R.
        • Bryant A.S.
        • et al.
        The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis.
        Ann Thorac Surg. 2011; 91: 1642-1648
        • Mago R.
        Glycopyrrolate for antidepressant-associated excessive sweating.
        J Clin Psychopharmacol. 2013; 33: 279-280
        • Lakraj A.D.
        • Moghimi N.
        • Jabbari B.
        Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.
        Toxins (Basel). 2013; 5: 821-840
        • Bajaj V.
        • Langtry J.A.
        Use of oral glycopyrronium bromide in hyperhidrosis.
        Br J Dermatol. 2007; 157: 118-121
        • Walling H.W.
        Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
        J Am Acad Dermatol. 2012; 66: 387-392
        • Messikh R.
        • Elkhyat A.
        • Aubin F.
        • et al.
        Use of oral oxybutynin at 7.5 mg per day in primary hyperhidrosis.
        Rev Med Liege. 2012; 67 ([in French]): 520-526
        • Tupker R.A.
        • Harmsze A.M.
        • Deneer V.H.M.
        Oxybutynin therapy for generalized hyperhidrosis.
        Arch Dermatol. 2006; 148: 1065-1086
        • Wolokser N.
        • de Campos J.R.
        • Kauffman P.
        • et al.
        A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
        J Vasc Surg. 2012; 55: 1696-1700
        • Wolosker N.
        • Krutman M.
        • Campdell T.P.
        • et al.
        Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders.
        Einstein (Sao Paulo). 2012; 10: 405-408
        • Wolosker N.
        • Krutman M.
        • Kauffman P.
        • et al.
        Oxybutynin treatment for hyperhidrosis in overweight and obese patients.
        Rev Assoc Med Bras. 2013; 59: 143-147
        • Müller C.
        • Berensmeier A.
        • Hamm H.
        • et al.
        Efficacy and safety of methantheline bromide (vagantin) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
        J Eur Acad Dermatol Venereol. 2013; 27: 1278-1284
        • Paller A.S.
        • Shah P.R.
        • Silverio A.M.
        • et al.
        Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
        J Am Acad Dermatol. 2012; 67: 918-923
        • Armstrong R.B.
        • Dmochowski R.R.
        • Sand P.K.
        • et al.
        Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
        Int Urol Nephrol. 2007; 39: 1069-1077
        • Gish P.
        • Mosholder A.D.
        • Truffa M.
        • et al.
        Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
        J Pediatr. 2009; 155: 432-434
        • Mier R.J.
        • Bachrach S.J.
        • Lakin R.C.
        • et al.
        Treatment of sialorrhea with glycopyrrolate: a double-blind dose-ranging study.
        Arch Pediatr Adolesc Med. 2000; 154: 1214-1218
        • Schneier R.F.
        Social anxiety disorder.
        N Engl J Med. 2006; 355: 1029-1036
        • Brown J.
        • Laiken N.
        Chapter 9, Muscarinic receptor agonists and antagonists.
        in: Brunton L.L. Chabner B.A. Knollmann B.C. Goodman & Gilman's the pharmacological basis of therapeutics. 12th edition. McGraw-Hill, New York, NY2011 (Available at:) (Accessed July 24, 2014)
        • Feder R.
        Clonidine treatment of excessive sweating.
        J Clin Psychiatry. 1995; 56: 35
        • Nelson H.D.
        • Vesco K.K.
        • Haney E.
        • et al.
        Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
        JAMA. 2006; 295: 2057-2071
        • Torch E.M.
        Remission of facial and scalp hyperhidrosis with clonidine hydrochloride and topical aluminum chloride.
        South Med J. 2000; 93: 68-69
        • Böni R.
        Generalized hyperhidrosis and its systemic treatment.
        Curr Probl Dermatol. 2002; 30: 44-47
        • James W.D.
        • Schoomaker E.B.
        • Rodman O.C.
        Emotional eccrine sweating. A heritable disorder.
        Arch Dermatol. 1987; 123: 925-929
        • Tkach J.R.
        Indomethacin treatment of generalized hyperhidrosis.
        J Am Acad Dermatol. 1982; 6: 545
        • Adams B.B.
        • Vargus-Adams J.N.
        • Franz D.N.
        • et al.
        Hyperhidrosis in pediatric spinal cord injury: a case report and gabapentin therapy.
        J Am Acad Dermatol. 2002; 46: 444-446